Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy-Reference-Cited by-同舟云学术

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy

Published:2009-02-04 Issue:5 Volume:49 Page:1503-1514
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Tenney Daniel J.,Rose Ronald E.,Baldick Carl J.,Pokornowski Kevin A.,Eggers Betsy J.,Fang Jie,Wichroski Michael J.,Xu Dong,Yang Joanna,Wilber Richard B.,Colonno Richard J.

Publisher

Wiley

Subject

Hepatology

Reference38 articles.

1. Hepatitis B virus infection: epidemiology and vaccination;Shepard;Epidemiol Rev,2006

2. Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach;Pawlotsky;Gastroenterology,2008

3. Chronic hepatitis B;Lok;HEPATOLOGY,2007

4. The impact of drug resistance on the effectiveness of chemotherapy for chronic hepatitis B;Richman;HEPATOLOGY,2000

5. Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B;Lai;Clin Infect Dis,2003

Cited by 712 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review and meta-analysis of the risk of hepatitis B virus (HBV) resistance in people treated with entecavir or tenofovir;Journal of Clinical Virology;2024-10

2. Hepatitis B Management in the Middle East: A Narrative Review of Current Antiviral Treatments;Gastrointestinal Disorders;2024-09-12

3. QSPR analysis of drugs used for treatment of hepatitis via reduced reverse degree-based topological descriptors;Physica Scripta;2024-09-06

4. Viral Hepatitis: Host Immune Interaction, Pathogenesis and New Therapeutic Strategies;Pathogens;2024-09-05

5. Current trends and advances in antiviral therapy for chronic hepatitis B;Chinese Medical Journal;2024-06-28